Evidence map›Paper›PMID 40092507›Full record

ArticlePlastic and reconstructive surgery. Global open2025

Swallowing and Speaking Evaluation After Resection and Reconstruction Versus Definite Radiochemotherapy for (Sub)total Tongue Cancer.

Tobias Ettl, Johannes K Meier, Peter Kummer, Fabian Pohl, Michael Gerken, Torsten E Reichert, Christopher Bohr, Sarah Vester

Abstract read
In one paragraph

Article in Plastic and reconstructive surgery. Global open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Tobias EttlFrom the Department of Oral and Maxillofacial Surgery, Regensburg University Hospital, Regensburg, Germany.
Johannes K MeierFrom the Department of Oral and Maxillofacial Surgery, Regensburg University Hospital, Regensburg, Germany.
Peter KummerDepartment of Otorhinolaryngology, Regensburg University Hospital, Regensburg, Germany.
Fabian PohlDepartment for Radiotherapy, Regensburg University Hospital, Regensburg, Germany.
Michael GerkenTumor Center-Center for Quality Management and Health Services Research, Regensburg University, Regensburg, Germany.
Torsten E ReichertFrom the Department of Oral and Maxillofacial Surgery, Regensburg University Hospital, Regensburg, Germany.
Christopher BohrDepartment of Otorhinolaryngology, Regensburg University Hospital, Regensburg, Germany.
Sarah VesterDepartment of Otorhinolaryngology, Regensburg University Hospital, Regensburg, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: In very advanced tongue cancer, definite radiochemotherapy (RCHT) is often preferred over total or near total glossectomy due to organ preservation and functionality, particularly swallowing. Methods: This retrospective study compares the functionality and survival of 10 patients with very advanced tongue cancer who received (sub)total glossectomy with prior or adjuvant RCHT and reconstruction by a musculocutaneous anterolateral thigh flap. All 10 patients had comparable tongue carcinomas treated by definite RCHT. Airway protection and swallow efficiency were evaluated by fiberoptic endoscopic evaluation of swallowing and graded using the Rosenbek Penetration and Aspiration Scale (PAS) and the Yale Pharyngeal Residue Severity Rating Scale (YPRS). Results: Of 10 surgical patients, 7 were completely oralized after a mean of 17 days. For surgical patients, PAS scores swallowing saliva (mean 1.6 versus 2.9, Conclusions: Patients after (sub)total glossectomy with RCHT and adequate reconstruction with a musculocutaneous anterolateral thigh flap show equal or even better swallowing compared with patients after definite RCHT for advanced tongue cancer.

Identifiers

PMID40092507
PMCPMC11908755

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.